HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $9 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on InflaRx (NASDAQ:IFRX) and maintained a price target of $9.
August 31, 2023 | 8:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
InflaRx's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $9.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for InflaRx. The maintained price target of $9 indicates the firm's confidence in the stock's potential to reach this price, which could attract investors and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100